Literature DB >> 30833151

Sexual Dysfunction in Women With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.

Ana Carolina Firmino Murgel1, Ricardo Santos Simões2, Gustavo Arantes Rosa Maciel1, José Maria Soares1, Edmund Chada Baracat1.   

Abstract

INTRODUCTION: Sexual dysfunction occurs in any phase of sexual performance or any period of the sexual response cycle, and polycystic ovary syndrome (PCOS) affects self-image with repercussions on sexuality. AIM: To evaluate sexual dysfunction in women with PCOS.
METHODS: A systematic review was undertaken following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis. The primary databases MEDLINE, EMBASE, Cochrane, and Lilacs were accessed using specific terms. There was no constraint against year of publication. The meta-analysis was conducted with RevMan program version 5.3. MAIN OUTCOME MEASURE: We evaluated the relationship between sexual dysfunction and PCOS.
RESULTS: The systematic review encompassed 19 studies. The analysis indicated that 11 specific and 6 general instruments were used to measure the sexual function in PCOS women. Of these, the Female Sexual Function Index scale was used most frequently. All studies assessed different aspects of sexual performance in PCOS women, and no difference was found in between women with PCOS and control subjects. CLINICAL IMPLICATIONS: Although there were disparities regarding ethnicity, culture, religion, and economy among studies, the available evidence failed to prove a significant link between PCOS and sexual dysfunction. STRENGTH & LIMITATIONS: This systematic review addressed a multidimensional theme with many variables and with a wide diversity of measurement tools. Studies were small, and populations were not homogeneous.
CONCLUSION: Despite potential risk of bias, such as inhomogeneity of study population, sexual function of both PCOS patients and women with regular menstrual cycles might, in general, be similar. Firmino Murgel AC, Santos Simões R, Maciel GAR, et al. Sexual Dysfunction in Women With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. J Sex Med 2019;16:542-550.
Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ovary Syndrome; Polycystic Ovary Syndrome; Sexual Activity; Sexual Behavior; Sexual Disorders; Sexual Dysfunction; Sexuality; Stein-Leventhal Syndrome

Mesh:

Year:  2019        PMID: 30833151     DOI: 10.1016/j.jsxm.2019.01.313

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Body image and sexual function in women with polycystic ovary syndrome: a case-control study.

Authors:  Yılda Arzu Aba; Bulat Aytek Şik
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

2.  Psychological Issues and Sexual Function in Women with Different Infertility Causes: Focus on Polycystic Ovary Syndrome.

Authors:  Iuliia Naumova; Camil Castelo-Branco; Gemma Casals
Journal:  Reprod Sci       Date:  2021-03-24       Impact factor: 3.060

3.  Differences in and Correlates of Sexual Function in Infertile Women with and without Polycystic Ovary Syndrome.

Authors:  Azadeh Akbari Sene; Bita Tahmasbi; Farideh Keypour; Hadi Zamanian; Fahimeh Golbabaei; Mohammadali Amini-Tehrani
Journal:  Int J Fertil Steril       Date:  2021-01-19

4.  The Effective Factors on The Sexual Function of Polycystic Ovary Syndrome Women: A Cross-Sectional Study.

Authors:  Bita Fereidooni; Ensieh Jenabi; Salman Khazaei; Sara Abdoli
Journal:  Int J Fertil Steril       Date:  2022-08-21

5.  Fecundability in reproductive aged women at risk of sexual dysfunction and associated risk factors: a prospective preconception cohort study.

Authors:  Tse Yeun Tan; Jerry Kok Yen Chan; See Ling Loy; Chee Wai Ku; Yin Bun Cheung; Keith M Godfrey; Yap-Seng Chong; Lynette Pei-Chi Shek; Kok Hian Tan; Fabian Kok Peng Yap; Jonathan Y Bernard; Helen Chen; Shiao-Yng Chan
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-25       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.